| Code | 7141B | ||||||||||
| MA number | 31/0512/15-S | ||||||||||
| Product Form: | tbl 100x10 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 15.12.2015 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ezetimibe Glenmark 10 mg tablety_07.2021.pdf
|
| PIL: |
PIL_Ezetimibe Glenmark 10 mg tablety_04.2024.pdf
|
| Safety feature | Yes |
| Data update: | 26.02.2021 |
